Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy

Successful cancer immunotherapy is confounded by the magnitude of the tumor burden and the presence of immunoregulatory elements that suppress an immune response. To approach these issues, 26 patients with advanced treatment refractory cancer were enrolled in a safety/feasibility study wherein a con...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasumi, Kenichiro, Aoki, Yukimasa, Watanabe, Ryuko, Hankey, Kim G., Mann, Dean L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757414/
https://www.ncbi.nlm.nih.gov/pubmed/24212806
http://dx.doi.org/10.3390/cancers3022223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757414/
https://www.ncbi.nlm.nih.gov/pubmed/24212806
http://dx.doi.org/10.3390/cancers3022223

Ejemplares similares